Bruce Booth - Director at Sionna Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
SION on Nasdaq
All Insider Reports
All Insider Reports

Bruce Booth - trading volume in the past year for Sionna Therapeutics, Inc.

Holdings reported by Bruce Booth for Sionna Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2,309,035 $84,095,054 $36.42 21 Oct 2025 By Atlas Venture Fund XI, L.P.
Common Stock 686,567 $25,004,770 $36.42 21 Oct 2025 By Atlas Venture Opportunity Fund II, L.P.
Non-Qualified Stock Option (right to buy) 19,959 12 Jun 2025 Direct Common Stock
Series A convertible preferred stock 0 10 Feb 2025 By Atlas Venture Fund XI, L.P. Common Stock
Series B convertible preferred stock 0 10 Feb 2025 By Atlas Venture Fund XI, L.P. Common Stock
Series C convertible preferred stock 0 10 Feb 2025 By Atlas Venture Fund XI, L.P. Common Stock
Series C convertible preferred stock 0 10 Feb 2025 By Atlas Venture Opportunity Fund II, L.P. Common Stock
Series Seed convertible preferred stock 0 10 Feb 2025 By Atlas Venture Fund XI, L.P. Common Stock

Transactions reported by Bruce Booth for Sionna Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.